Moderna, Inc. Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Moderna, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2018 to Q2 2024.
  • Moderna, Inc. Net Income (Loss) Attributable to Parent for the quarter ending June 30, 2024 was -$1.28B, a 7.32% increase year-over-year.
  • Moderna, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending June 30, 2024 was -$5.87B, a 586% decline year-over-year.
  • Moderna, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$4.71B, a 156% decline from 2022.
  • Moderna, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was $8.36B, a 31.5% decline from 2021.
  • Moderna, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was $12.2B.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$5.87B -$1.28B +$101M +7.32% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 -$5.97B -$1.18B -$1.25B -1587% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 -$4.71B $217M -$1.25B -85.2% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-23
Q3 2023 -$3.47B -$3.63B -$4.67B -448% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $1.21B -$1.38B -$3.58B -163% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $4.78B $79M -$3.58B -97.8% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $8.36B $1.47B -$3.4B -69.9% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-23
Q3 2022 $11.8B $1.04B -$2.29B -68.7% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-03
Q2 2022 $14.1B $2.2B -$583M -21% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $14.6B $3.66B +$2.44B +200% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $12.2B $4.87B +$5.14B Oct 1, 2021 Dec 31, 2021 10-K 2024-02-23
Q3 2021 $7.06B $3.33B +$3.57B Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $3.5B $2.78B +$2.9B Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-03
Q1 2021 $598M $1.22B +$1.35B Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-04
Q4 2020 -$747M -$273M -$150M -121% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 -$597M -$233M -$110M -89.1% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$487M -$117M +$17.9M +13.3% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$505M -$124M +$8.58M +6.47% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$514M -$123M +$18.2M +12.8% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 -$532M -$123M -$42.9M -53.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-10-30
Q2 2019 -$489M -$135M -$44.3M -48.9% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$445M -$133M -$60.2M -83.2% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$385M -$141M Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 -$80.3M Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 -$90.6M Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 -$72.4M Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.